Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients

Zamboglou C(2019)Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference Theranostics 9 2595-2605

Carles M(2020)18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients Eur J Nucl Med Mol Imaging 47 1116-1126

Fechter T(2016)Radiomics: images are more than pictures, they are data Radiology 278 563-577

Li P(2000)Management of patients with rising prostate-specific antigen after radical prostatectomy Urology 55 309-315

Wang X(2000)Prostate specific antigen only progression of prostate cancer J Urol 163 1632-1642

Xu C(2012)Cause-specific mortality following radical prostatectomy Prostate Cancer Prostatic Dis 15 106-110

Gillies RJ(2015)Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer J Urol 194 1624-1630

Kinahan PE(2014)The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis Br J Radiol 87 20140065-366

Hricak H(2017)Radiomics in PET/CT: more than meets the eye? J Nucl Med 58 365-1303

Laufer M(2020)New artificial intelligence model for 18F-choline PET/CT in evaluation of high-risk prostate cancer outcome: texture analysis and radiomics features classification for prediction of disease progression J Nucl Med 61 1303-974

Zamboglou C(2019)Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference Theranostics 9 2595-2605

Carles M(2020)18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients Eur J Nucl Med Mol Imaging 47 1116-1126

Fechter T(2016)Radiomics: images are more than pictures, they are data Radiology 278 563-577

Li P(2000)Management of patients with rising prostate-specific antigen after radical prostatectomy Urology 55 309-315

Wang X(2000)Prostate specific antigen only progression of prostate cancer J Urol 163 1632-1642

Xu C(2012)Cause-specific mortality following radical prostatectomy Prostate Cancer Prostatic Dis 15 106-110

Gillies RJ(2015)Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer J Urol 194 1624-1630

Kinahan PE(2014)The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis Br J Radiol 87 20140065-366

Hricak H(2017)Radiomics in PET/CT: more than meets the eye? J Nucl Med 58 365-1303

Laufer M(2020)New artificial intelligence model for 18F-choline PET/CT in evaluation of high-risk prostate cancer outcome: texture analysis and radiomics features classification for prediction of disease progression J Nucl Med 61 1303-974